Subcutaneous Anti-tnf-α in Rheumatoid Arthritis: Analyze the Correlation Between Objective Measures of Disease Activity and Safety and a Subjective Measure Such As Patient Beliefs About a Medicine.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Tumour necrosis factor alpha inhibitors
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms CONTENT
Most Recent Events
- 20 Jan 2016 Biomarkers information updated
- 16 Dec 2013 Planned end date changed from 1 Nov 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 15 Nov 2013 Planned end date changed from 1 Oct 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.